There is no official FDA black box warning specifically linking tirzepatide to gallstones , but the prescribing information for both Mounjaro and Zepbound includes warnings about acute gallbladder disease, noting that cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) were observed in clinical trials
At a 2.5 mg weekly dose, that's 8 weeks of therapy
Clinical Evidence and Trial Results Retatrutide has undergone rigorous clinical testing, with Phase 2 trials providing detailed data on its effectiveness for weight reduction
These forward-looking statements can be identified by the use of forward-looking terminology, including the words anticipates, expects, intends, plans, decides, may, will, likely, potential, future, coming, starting, hope, or should, or, in each case, their negative or other variations or comparable terminology
Download transcript (PDF) Transcription services provided by 3Play Media.